indoles. In particular, of great interest to us was the formation
of 4a (albeit in very poor yield), in which two carbon-
nitrogen bonds are formed in a single operative step. The
conversion of this side reaction into a synthetically useful
process would add to known procedures based on the
cyclization of o-alkynylanilines and o-alkynylanilides6 a new
useful approach for the assembly of the functionalized pyrrole
nucleus incorporated into the indole system (Scheme 2) and
Scheme 3
Scheme 2. Retrosynthetic Representation of the
Palladium-Catalyzed Assembly of the Pyrrole Nucleus from
Ethyl 3-(o-Trifluoroacetamidophenyl)-1-propargyl Carbonate 1a
Part of our optimization work using different catalyst
systems and solvents is summarized in Table 1. p-Iodoanisole
Table 1. Examination of the Reaction of Ethyl
3-(o-Trifluoroacetamidophenyl)-1-propargyl Carbonate 1a with
N-Ethylpiperazine 5aa
entry
catalyst system
solvent
time (h)
yield % of 6ab
open a straightforward route to an important class of indole
derivatives. Indeed, the 2-(aminomethyl)indole motif is a key
structural feature present in several biologically active
compounds.7 In particular, 2-(piperazin-1-ylmethyl)indoles,
containing two privileged substructures (the indole and
piperazine nuclei),8 exhibit important biological activities and
have attracted considerable attention in organic, medical, and
pharmaceutical chemistry.9
Therefore, the development of a protocol for the prepara-
tion of 2-(piperazin-1-ylmethyl)indoles 6 from 1a and
piperazines 5 (Scheme 3) was initially explored when we
started this research project.
Compound 1a was prepared through a four-step process
from o-iodoaniline via Sonogashira cross-coupling with the
tetrahydropyranyl derivative of propargyl alcohol followed
by trifluoroacetylation, deprotection, and esterification steps
in 80% overall isolated yield, omitting isolation and char-
acterization of reaction intermediates.
1
2
3
4
5
6
7
8
Pd(OAc)2, PPh3
Pd2(dba)3, PPh3
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd2(dba)3, dppf
Pd2(dba)3, dppe
PdCl2(2-furyl)2
THF
THF
MeCN
DMF
THF
THF
THF
THF
6
6
6
6
1.5
6
52
58
57c
54c
91
85
50
33
24
24
a Unless otherwise stated, reactions were carried out on a 0.159 mmol
scale in 1 mL of solvent under argon at 80 °C by using 1 equiv of 1a, 3
equiv of 5a, 0.05 equiv of [Pd], 0.1 equiv of PPh3, or 0.05 equiv of bidentate
phosphine ligand. b Yields are given for isolated products. c With 0.05 equiv
of Pd(PPh3)4.
(which did not enter the catalytic cycle affording isolated
products) and formic acid (very likely involved in the
formation of 3) were omitted. Moderate yields were obtained
under a variety of reaction conditions (Table 1, entries 1-4).
The best result in terms of yield and reaction time was
obtained in the presence of Pd(PPh3)4 in THF (Table 1, entry
5). Longer reaction times and lower yields were observed
with Pd2(dba)3 and bidentate ligands such as dppf and dppe
(Table 1, entries 6 and 7). A longer reaction time and lower
yield were also observed using the less reactive propargyl
acetate10 1b as the starting alkyne (50% yield; Pd(PPh3)4,
THF, 80 °C, 24 h). A slight increase of the yield (67%) was
observed with 1b at 100 °C after 9 h, but the yield was still
significantly lower than that with 1a.
The best conditions found for 1a [Pd(PPh3)4, THF, 80 °C]
proved to be very efficient for a number of related cycliza-
tions to 2-(piperazin-1-ylmethyl)indoles as indicated in Table
2. Only with 5j (Table 2, entry 10), the desired indole product
was isolated in moderate yield, very likely because of the
low nucleophilicity of the nitrogen derivative due to steric
effects.
(6) Cacchi, S.; Fabrizi, G. Chem. ReV. 2005, 105, 2873.
(7) See, for example: (a) Moro´n, J. A.; Campillo, M.; Perez, V.; Unzeta,
M.; Pardo, L. J. Med. Chem. 2000, 43, 1684. See also: (b) Spadoni, G.;
Balsamini, C.; Diamantini, G.; Tontini, A.; Tarzia, G.; Mor, M.; Rivara,
S.; Plazzi, P. V.; Nonno, R.; Lucini, V.; Pannacci, M.; Fraschini, F.; Stankov,
B. M. J. Med. Chem. 2001, 44, 2900. (c) Spadoni, G.; Balsamini, C.; Bedini,
A.; Diamantini, G.; Di Giacomo, B.; Tontini, A.; Tarzia, G.; Mor, M.; Plazzi,
P. V.; Rivara, S.; Nonno, R.; Pannacci, M.; Lucini, V.; Fraschini, F.;
Stankov, B. M. J. Med. Chem. 1998, 41, 3624.
(8) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. ReV. 2003, 103,
893.
(9) For some recent references, see: (a) Hu¨bner, H.; Gmeiner, P.;
Kraxner, J. J. Med. Chem. 2000, 43, 4563. (b) Clifford, J. J.; Waddington,
J. L. Neuropsychopharmacol. 2000, 22, 538. Ortner, B.; Waibel, R.;
Gmeiner, P. Angew. Chem., Int. Ed. 2001, 40, 1283. (c) Moll, A.; Hu¨bner,
H.; Gmeiner, P.; Troschutz, R. Bioorg. Med. Chem. 2002, 10, 1671. (d)
Brioni, J. D.; Kolasa, T.; Hsieh, G. C.; Donnelly-Roberts, D. L. WO
2002041894, 2002; Chem. Abstr. 2002, 136, 395987. (e) Fliri, A. F. J.;
Sanner, M. A.; Seymour, P. A.; Zorn, S. H. Eur. Patent 1177792, 2002;
Chem. Abstr. 2002, 136, 145264. (f) Fliri, A. F. J.; Majchrzak, M. J.;
Seymour, P. A.; Zorn, S. H.; Rollema, H. U.S. Patent 842,569, 2003; Chem.
Abstr. 2003, 138, 401610. (g) Cowart, M.; Latshaw, S. P.; Bhatia, P.;
Daanen, J. F.; Rohde, J.; Nelson, S. L.; Patel, M.; Kolasa, T.; Nakane, M.;
Uchic, M. E.; Miller, L. N.; Terranova, M. A.; Chang, R.; Donnelly-Roberts,
D. L.; Namovic, M. T.; Hollingsworth, P. R.; Martino, B. R.; Lynch, J. J.,
III.; Sullivan, J. P.; Hsieh, G. C.; Moreland, R. B.; Brioni, J. D. S.; Andrew,
O. J. Med. Chem. 2004, 47, 3853. (h) Stewart, A. O.; Cowart, M. D.;
Moreland, R. B.; Latshaw, S. P.; Matulenko, M. A.; Bhatia, P. A.; Wang,
X.; Daanen, J. F.; Nelson, S. L.; Terranova, M. A.; Namovic, M. T.;
Donnelly-Roberts, D. L.; Miller, L. N.; Nakane, M.; Sullivan, J. P.; Brioni,
J. D. J. Med. Chem. 2004, 47, 2348.
Then, the extension of the reaction to other secondary
amines and even to primary amines was briefly investigated
(10) For a review on the palladium-catalyzed reactions of propargyl
esters, see: (a) Tsuji, J.; Mandai, T. Angew. Chem., Int. Ed. Engl. 1995,
34, 2589.
2084
Org. Lett., Vol. 8, No. 10, 2006